Park Avenue Securities LLC Repligen Corp Transaction History
Park Avenue Securities LLC
- $8.9 Billion
- Q3 2024
A detailed history of Park Avenue Securities LLC transactions in Repligen Corp stock. As of the latest transaction made, Park Avenue Securities LLC holds 3,125 shares of RGEN stock, worth $431,781. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,125
Previous 3,338
6.38%
Holding current value
$431,781
Previous $421,000
10.45%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding RGEN
# of Institutions
497Shares Held
53.9MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.05 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$700 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$637 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$240 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$196 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.67B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....